VKTXViking Therapeutics, Inc.

Nasdaq vikingtherapeutics.com


$ 67.00 $ -3.10 (-4.42 %)    

Friday, 17-May-2024 15:59:54 EDT
QQQ $ 451.63 $ -1.20 (-0.27 %)
DIA $ 399.76 $ 0.64 (0.16 %)
SPY $ 529.24 $ 0.31 (0.06 %)
TLT $ 91.40 $ -0.22 (-0.24 %)
GLD $ 223.63 $ 1.39 (0.63 %)
$ 69.06
$ 70.10
$ 0.00 x 0
$ 67.02 x 100
$ 66.74 - $ 71.10
$ 8.28 - $ 99.41
7,491,673
na
7.14B
$ 1.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-07-2024 12-31-2023 10-K
3 10-25-2023 09-30-2023 10-Q
4 07-26-2023 06-30-2023 10-Q
5 04-26-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-K
7 10-26-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 04-27-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-17-2021 12-31-2020 10-K
15 10-28-2020 09-30-2020 10-Q
16 07-29-2020 06-30-2020 10-Q
17 04-30-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 03-13-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-07-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-21-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-08-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-14-2015 06-30-2015 10-Q
37 06-12-2015 03-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet

The Benzinga Stock Whisper highlights five stocks weekly that are seeing increased interest from readers.

 raymond-james-upgrades-viking-therapeutics-to-strong-buy-raises-price-target-to-116

Raymond James analyst Steven Seedhouse upgrades Viking Therapeutics (NASDAQ:VKTX) from Outperform to Strong Buy and raises t...

 truist-securities-reiterates-buy-on-viking-therapeutics-maintains-120-price-target

Truist Securities analyst Joon Lee reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $120 price target.

 hc-wainwright--co-reiterates-buy-on-viking-therapeutics-maintains-90-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $90 p...

 viking-therapeutics-reports-q1-results-an-exceptional-period-says-ceo

Viking Therapeutics reports quarterly losses of 26 cents per share which beat the analyst consensus estimate of losses of 28 ce...

 viking-therapeutics-q1-eps-026-beats-028-estimate

Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION